Article 49PNZ Sackler behind OxyContin fraud offered twisted, mind-boggling defense

Sackler behind OxyContin fraud offered twisted, mind-boggling defense

by
Beth Mole
from Ars Technica - All content on (#49PNZ)
GettyImages-1090645444-800x533.jpg

Enlarge / BOSTON, MA - JANUARY 25: Families who have lost loved ones to the opioid crisis protest in front of Suffolk Superior Court in Boston as lawyers for Purdue Pharma enter the courthouse for a status update in the Attorney General's suit against Purdue Pharma. (credit: Getty | Boston Globe)

Richard Sackler turned to verbal acrobatics and leaps in logic to try to dodge blame in the fraudulent marketing of Purdue's potent opioid, OxyContin. The contorted explanations-which at points involved creating new definitions of words and claiming an enigmatic level of politeness-were first unveiled Thursday, February 21 from a sealed, 337-page deposition obtained by ProPublica.

The deposition was taken in August of 2015 as part of lawsuit brought by the state of Kentucky, which alleged Purdue illegally promoted its potent opioid painkiller. Back in 2007, federal prosecutors made similar allegations against Purdue, resulting in the company and three executives pleading guilty to misleading doctors, regulators, and patients over OxyContin's addictiveness. Numerous legal complaints have piled up against Purdue in the aftermath. Purdue settled many of them, including Kentucky's, which it settled for $24 million.

Yet in all the court battles, the mega-rich, secretive family behind Purdue, the Sacklers, have largely gone unscathed. In fact, the newly disclosed 2015 deposition is believed to be the only time a member of the Sackler family has been questioned over the fraudulent marketing.

Read 13 remaining paragraphs | Comments

index?i=udxTOGWzecE:oZIc69oPPIM:V_sGLiPB index?i=udxTOGWzecE:oZIc69oPPIM:F7zBnMyn index?d=qj6IDK7rITs index?d=yIl2AUoC8zA
External Content
Source RSS or Atom Feed
Feed Location http://feeds.arstechnica.com/arstechnica/index
Feed Title Ars Technica - All content
Feed Link https://arstechnica.com/
Reply 0 comments